Quick Takeaways:
- PetMed Express has received an unsolicited, non-binding proposal from SilverCape Investments to acquire all outstanding shares for $3.00 per share in cash, lower than SilverCape’s previous $4.00-per-share proposal made in December 2025.
- The board said it will evaluate the proposal with its financial and legal advisors and is prepared to engage with SilverCape once it signs a customary non-disclosure agreement containing a standstill provision.
- PetMeds noted that SilverCape declined to sign the required confidentiality agreement during the earlier sale process despite being invited to participate alongside other potential bidders, and emphasized that no decision has been made on the latest proposal.
Why It Matters?
SilverCape’s lower $3.00/share proposal keeps PetMed Express in play as a potential takeout target, but the reduced price weakens the bid’s attractiveness and gives the board room to push for better terms or shop alternatives. Market-wise, it signals that any deal will likely hinge on renewed bidder engagement under tighter process controls, so investors should view this as optionality rather than a near-certain acquisition.
Source: Globenewswire
